Eprosartan arginyl charge-neutralization-complex and a...

Details Eprosartan arginyl charge-neutralization-complex and a... Eprosartan arginyl charge-neutralization-complex and a...

A - Human Necessities

61

K

A61K 31/415 (2006.01) C07D 233/02 (2006.01) C07D 233/04 (2006.01) C07D 409/06 (2006.01)

Patent

CA 2299470

This invention relates to (E)-.alpha.-[2-n-butyl-1-[(4-carboxyphenyl)methyl)- 1H-imidazol-5-yl]methylene-2-thiophenepropionic acid arginyl charge-neutralization-complex, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.

L'invention concerne un complexe à neutralisation de charge de L-arginine d'acide (E)- alpha -[2-n-butyl-1-[(4-carboxyphényl)méthyl]-1H-imidazol-5-yl]méthylène-2-thiophènepropionique, son procédé de production, des compositions renfermant ce composé, et des procédés d'utilisation de ce composé visant à bloquer les récepteurs de l'angiotensine II et à traiter l'hypertension, l'insuffisance cardiaque globale, et l'insuffisance rénale.

Affiliated with

Also associated with

Rating

Eprosartan arginyl charge-neutralization-complex and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Eprosartan arginyl charge-neutralization-complex and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eprosartan arginyl charge-neutralization-complex and a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1544752